Enfortumab Vedotin With or Without Pembrolizumab in Rare Genitourinary Tumors (E-VIRTUE)

Clinical trial NCT06041503 · RECRUITING

Trial details

NCT number: NCT06041503
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of the Bladder Squamous Cell Carcinoma of the Bladder Testicular Germ Cell Tumors

Start date: 2026-01-20
Primary completion: 2027-10-01
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.